β¨ Medicines Notices
30 OCTOBER NEW ZEALAND GAZETTE 3661
Health
Medicines Act 1981
Provisional Consent to the Distribution of a New Medicine
Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Bretylium tosylate 50 mg/mL in 10 mL | Injection, vial and ampoule | Abbott Laboratories, Rocky Mount, North Carolina, United States of America | β |
Note: This consent is valid for 2 years from the date of publication of this notice.
Dated this 21st day of October 1997.
G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of October 1997.
go7652
Provisional Consent to the Distribution of a New Medicine
Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Interferon beta-1a 30 mcg and water for injection 2 mL as diluent | Powder for injection, vial; diluent, ampoule | Ben Venue Laboratories Inc., Bedford, Ohio, United States of America; Delta West Pty Limited, Bentley, Western Australia, Australia (diluent only) | Avonex |
Note: This consent is valid for 2 years from the date of publication of this notice.
Dated this 24th day of October 1997.
G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.
go7772
Renewal of Provisional Consent to the Distribution of a New Medicine
Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Warfarin sodium 1 mg, 2 mg, 5 mg | Tablets | The Boots Company PLC., Nottingham, United Kingdom | Coumadin |
Note: This consent is valid for 2 years from the 31st day of October 1997.
Dated this 24th day of October 1997.
G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.
go7773
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1997, No 155
NZLII —
NZ Gazette 1997, No 155
β¨ LLM interpretation of page content
π₯ Provisional Consent for Bretylium Tosylate
π₯ Health & Social Welfare21 October 1997
Medicines Act 1981, Provisional Consent, Bretylium Tosylate, Abbott Laboratories
- G. R. Boyd, Chief Advisor, Regulation and Safety
π₯ Provisional Consent for Interferon Beta-1a
π₯ Health & Social Welfare24 October 1997
Medicines Act 1981, Provisional Consent, Interferon Beta-1a, Avonex, Ben Venue Laboratories, Delta West Pty Limited
- G. R. Boyd, Chief Advisor, Regulation and Safety
π₯ Renewal of Provisional Consent for Warfarin Sodium
π₯ Health & Social Welfare24 October 1997
Medicines Act 1981, Provisional Consent Renewal, Warfarin Sodium, Coumadin, The Boots Company PLC
- G. R. Boyd, Chief Advisor, Regulation and Safety